Search

Search Constraints

You searched for: Author/Creator Hashine, Katsuyoshi

Search Results

1. Changes in perioperative management of radical prostatectomy using clinical pathways according to a standardized care plan: A multi‐institutional study. (23rd October 2012)

3. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

4. Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study. (18th March 2020)

5. Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external‐beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open‐label, randomized, phase 3 trial. Issue 17 (23rd June 2020)

7. Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial. (1st May 2021)

9. Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan. Issue 1 (December 2015)

10. Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer. (7th September 2022)